多沙普仑在中国维吾尔族和汉族健康人体内的药动学

夏东亚 程佳 曾平 尹东锋 刘璟 地里夏提·白克力 郭涛

中国药学杂志 ›› 2011, Vol. 46 ›› Issue (16) : 1269-1272.

PDF(670 KB)
PDF(670 KB)
中国药学杂志 ›› 2011, Vol. 46 ›› Issue (16) : 1269-1272.
论著

多沙普仑在中国维吾尔族和汉族健康人体内的药动学

  • 夏东亚1,程佳1,2,曾平3,尹东锋3,刘璟3,地里夏提·白克力3,郭涛1*
作者信息 +

Pharmacokinetics of Doxapram in Uigur and Han Healthy Volunteers in China

  • XIA Dong-ya1, CHENG Jia 1,2, ZENG Ping3, YIN Dong-feng3, LIU Jing3, DILIXIATIB·Ai-ke-li3,GUO Tao1*
Author information +
文章历史 +

摘要

目的 研究盐酸多沙普仑注射液在维吾尔族和汉族健康人体内的药动学。方法 选择维吾尔族和汉族健康受试者各10人,单次静脉滴注盐酸多沙普仑注射液50 mg。用高效液相色谱法测定血浆中多沙普仑的浓度。用DAS2.0药动学程序进行房室模型判断并计算药动学参数。结果 静脉滴注盐酸多沙普仑后的体内过程符合二室模型,维吾尔族和汉族受试者的主要药动学参数,t1/2α分别为(0.49±0.42)和(0.33±0.24) h,t1/2β分别为(3.65±2.07)和(3.87±2.17) h,Vc分别为(0.788±0.523)和(0.354±0.197) L·kg-1,Vd分别为(1.812±0.986)和(1.350±0.957) L·kg-1,CL分别为(0.394±0.251)和(0.245±0.113) L·h-1·kg-1,AUC0-12分别为(2.320±0.700)和(3.513±1.260) mg·h·L-1,AUC0-∞分别为(2.682±0.801)和(4.061±1.445) mg·h·L-1。结论 维吾尔族和汉族健康受试者单次静脉滴注盐酸多沙普仑后Vc、AUC0-12和AUC0-∞的差异有统计学意义。

Abstract

OBJECTIVE To study the pharmacokinetics of doxapram injection in Uigur and Han healthy volunteers. METHODS Ten Uigur and 10 Han healthy volunteers were given a single dose of 50 mg doxapram injection intravenously. The plasma concentrations of doxapram were determined by HPLC. The pharmacokinetic parameters were calculated with DAS2.0 software. RESULTS The plasma concentration-time curves of doxapram were fitted to a two-compartment model. The main pharmacokinetic parameters in Uigur and Han healthy volunteers were as follows: t1/2α (0.49±0.42) and (0.33±0.24)h, t1/2β (3.65±2.07) and (3.87±2.17) h, Vc (0.788±0.523) and (0.354±0.197)L·kg-1, Vd(1.812±0.986) and (1.350±0.957) L·kg-1, CL (0.394±0.251) and (0.245±0.113)L·h-1·kg-1, AUC0-12 (2.320±0.700) and (3.513±1.260)mg·h·L-1, AUC0-∞ (2.682±0.801) and (4.061±1.445) mg·h·L-1, respectively. CONCLUSION There is significant difference in the pharmacokinetic parameters Vc, AUC0-12, AUC0-∞ between Uigur and Han healthy volunteers.

关键词

多沙普仑 / 药动学 / 高效液相色谱法 / 维吾尔族

Key words

doxapram / pharmacokinetics / HPLC / Uigur

引用本文

导出引用
夏东亚 程佳 曾平 尹东锋 刘璟 地里夏提·白克力 郭涛. 多沙普仑在中国维吾尔族和汉族健康人体内的药动学[J]. 中国药学杂志, 2011, 46(16): 1269-1272
XI Dong-y;CHENG Ji;ZENG Ping;YIN Dong-feng;LIU Jing;DILIXITI·i-ke-li;GUO To. Pharmacokinetics of Doxapram in Uigur and Han Healthy Volunteers in China[J]. Chinese Pharmaceutical Journal, 2011, 46(16): 1269-1272

参考文献


[1] Ministry of Health Committee of Experts on Rational Drug Use. China Pharmaceutical Reference(中国医师药师临床医药指南)[M]. 1st ed. Chongqing: Chongqing Publishing House, 2009: 1120-1121.
[2] CHEN X Q, JIN Y Y, TANG G. New Pharmaceutics(新编药物学)[M]. 16th ed. Bejing: People’s Medical Publishing House, 2007: 166.
[3] CHENG J, XIA D Y, GUO T, et al. Determination of doxapram in human plasma by HPLC [J]. China Pharm(中国药师),2010,13(5): 618-619.
[4] AI Q H, XIAO H, ZHAO J X. A survey on physical characteristics of Uigur nationality [J]. Acta Anthropol Sin(人类学学报),1993,12(4):357-365.
[5] YANG J P, XU S X. Effect of gender on pharmacokinetics [J]. J China Pharm(中国药房),2005, 16(15):1188.
PDF(670 KB)

61

Accesses

0

Citation

Detail

段落导航
相关文章

/